The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Sanofi Pharma Bristol-Myers Squibb SNCEU/1/98/86/23-28

Main Information

Active SubstancesIRBESARTAN
Dosage FormTablet
Licence HolderSanofi Pharma Bristol-Myers Squibb SNC
Licence NumberEU/1/98/86/23-28

Group Information

ATC CodeC09DA04 irbesartan and diuretics


License statusAuthorised
Licence Issued28/08/2006
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back